Prevalence of Ivermectin use to prevent COVID-19 during the pandemic in Mato Grosso: cross-sectional home-based study
ABSTRACT Objective: To analyze the use of ivermectin as COVID-19 prevention method by the population of Mato Grosso in 2020. Methods: This is a home-based survey, carried out between September and October 2020, in 10 pole cities of the socioeconomic regions of State. The use of ivermectin was eval...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Associação Brasileira de Pós-Graduação em Saúde Coletiva
2023-05-01
|
| Series: | Revista Brasileira de Epidemiologia |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-790X2023000100424&lng=en&tlng=en |
| _version_ | 1827951469489291264 |
|---|---|
| author | Nathalia Beatriz Lobo da Silva Roseany Patrícia da Silva Rocha Amanda Cristina de Souza Andrade Ana Cláudia Pereira Terças-Trettel Ana Paula Muraro |
| author_facet | Nathalia Beatriz Lobo da Silva Roseany Patrícia da Silva Rocha Amanda Cristina de Souza Andrade Ana Cláudia Pereira Terças-Trettel Ana Paula Muraro |
| author_sort | Nathalia Beatriz Lobo da Silva |
| collection | DOAJ |
| description | ABSTRACT Objective: To analyze the use of ivermectin as COVID-19 prevention method by the population of Mato Grosso in 2020. Methods: This is a home-based survey, carried out between September and October 2020, in 10 pole cities of the socioeconomic regions of State. The use of ivermectin was evaluated through the question: “Did you take ivermectin to prevent COVID-19?”. Sociodemographic variables (sex, age group, education, family income), current work situation, being benefitted by government financial programs, as well as symptoms, seroprevalence of antibodies against SARS-CoV-2, and previous diagnosis of COVID-19 were evaluated. Prevalence and their associations were estimated using the chi-square test. Results: 4.206 individuals were evaluated for prevalence of ivermectin use; 58.3% of the individuals responded positively, this rate being higher in the municipalities of the western region of the state (66.6%). There was no significant difference between sexes, but the prevalence was higher among people aged 50–59 years (69.7%), who were white (66.5%), with complete higher education or more (68.8%) and higher family income (≥3 minimum wages-64.2%). The use of this drug was even higher among participants who considered their knowledge of the disease good or very good (65.0%), who reported having symptoms of COVID-19 (75.3%), and who had been previously diagnosed with the disease (91.2%). Conclusion: There was a high prevalence of use of ivermectin as a method to prevent covid-19 by the population of Mato Grosso, indicating the need for strategies to inform the population about the risks of off-label use of drugs and to combat the advertising of drugs that are ineffective against COVID-19. |
| first_indexed | 2024-04-09T13:42:14Z |
| format | Article |
| id | doaj.art-09f554c173a24b0bb7e077ada8dc26aa |
| institution | Directory Open Access Journal |
| issn | 1980-5497 |
| language | English |
| last_indexed | 2024-04-09T13:42:14Z |
| publishDate | 2023-05-01 |
| publisher | Associação Brasileira de Pós-Graduação em Saúde Coletiva |
| record_format | Article |
| series | Revista Brasileira de Epidemiologia |
| spelling | doaj.art-09f554c173a24b0bb7e077ada8dc26aa2023-05-09T07:34:30ZengAssociação Brasileira de Pós-Graduação em Saúde ColetivaRevista Brasileira de Epidemiologia1980-54972023-05-012610.1590/1980-549720230026Prevalence of Ivermectin use to prevent COVID-19 during the pandemic in Mato Grosso: cross-sectional home-based studyNathalia Beatriz Lobo da Silvahttps://orcid.org/0000-0002-3856-3461Roseany Patrícia da Silva Rochahttps://orcid.org/0000-0002-2295-5321Amanda Cristina de Souza Andradehttps://orcid.org/0000-0002-3366-4423Ana Cláudia Pereira Terças-Trettelhttps://orcid.org/0000-0001-8761-3325Ana Paula Murarohttps://orcid.org/0000-0001-6237-1673ABSTRACT Objective: To analyze the use of ivermectin as COVID-19 prevention method by the population of Mato Grosso in 2020. Methods: This is a home-based survey, carried out between September and October 2020, in 10 pole cities of the socioeconomic regions of State. The use of ivermectin was evaluated through the question: “Did you take ivermectin to prevent COVID-19?”. Sociodemographic variables (sex, age group, education, family income), current work situation, being benefitted by government financial programs, as well as symptoms, seroprevalence of antibodies against SARS-CoV-2, and previous diagnosis of COVID-19 were evaluated. Prevalence and their associations were estimated using the chi-square test. Results: 4.206 individuals were evaluated for prevalence of ivermectin use; 58.3% of the individuals responded positively, this rate being higher in the municipalities of the western region of the state (66.6%). There was no significant difference between sexes, but the prevalence was higher among people aged 50–59 years (69.7%), who were white (66.5%), with complete higher education or more (68.8%) and higher family income (≥3 minimum wages-64.2%). The use of this drug was even higher among participants who considered their knowledge of the disease good or very good (65.0%), who reported having symptoms of COVID-19 (75.3%), and who had been previously diagnosed with the disease (91.2%). Conclusion: There was a high prevalence of use of ivermectin as a method to prevent covid-19 by the population of Mato Grosso, indicating the need for strategies to inform the population about the risks of off-label use of drugs and to combat the advertising of drugs that are ineffective against COVID-19.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-790X2023000100424&lng=en&tlng=enCOVID-19Off-label useIvermectinCoronavirusCross-sectional study |
| spellingShingle | Nathalia Beatriz Lobo da Silva Roseany Patrícia da Silva Rocha Amanda Cristina de Souza Andrade Ana Cláudia Pereira Terças-Trettel Ana Paula Muraro Prevalence of Ivermectin use to prevent COVID-19 during the pandemic in Mato Grosso: cross-sectional home-based study Revista Brasileira de Epidemiologia COVID-19 Off-label use Ivermectin Coronavirus Cross-sectional study |
| title | Prevalence of Ivermectin use to prevent COVID-19 during the pandemic in Mato Grosso: cross-sectional home-based study |
| title_full | Prevalence of Ivermectin use to prevent COVID-19 during the pandemic in Mato Grosso: cross-sectional home-based study |
| title_fullStr | Prevalence of Ivermectin use to prevent COVID-19 during the pandemic in Mato Grosso: cross-sectional home-based study |
| title_full_unstemmed | Prevalence of Ivermectin use to prevent COVID-19 during the pandemic in Mato Grosso: cross-sectional home-based study |
| title_short | Prevalence of Ivermectin use to prevent COVID-19 during the pandemic in Mato Grosso: cross-sectional home-based study |
| title_sort | prevalence of ivermectin use to prevent covid 19 during the pandemic in mato grosso cross sectional home based study |
| topic | COVID-19 Off-label use Ivermectin Coronavirus Cross-sectional study |
| url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-790X2023000100424&lng=en&tlng=en |
| work_keys_str_mv | AT nathaliabeatrizlobodasilva prevalenceofivermectinusetopreventcovid19duringthepandemicinmatogrossocrosssectionalhomebasedstudy AT roseanypatriciadasilvarocha prevalenceofivermectinusetopreventcovid19duringthepandemicinmatogrossocrosssectionalhomebasedstudy AT amandacristinadesouzaandrade prevalenceofivermectinusetopreventcovid19duringthepandemicinmatogrossocrosssectionalhomebasedstudy AT anaclaudiapereiratercastrettel prevalenceofivermectinusetopreventcovid19duringthepandemicinmatogrossocrosssectionalhomebasedstudy AT anapaulamuraro prevalenceofivermectinusetopreventcovid19duringthepandemicinmatogrossocrosssectionalhomebasedstudy |